• Other

    Other
  • CN

    CN
  • EU

    EU
  • EN

    EN
    • 我的购物车
    购物车中还没有商品，赶紧选购吧！
    • 产品名称
    • 规格
    • 数量
    • 总价
      已选择商品 : 0 件 总计 : 结账()
      Navitoclax (ABT-263)
      Navitoclax (ABT-263)

      售价：
      市场价：

      产品仅用于科学研究，不针对患者销售
      数量： - + 件（库存件）
      InvivoChem目录号 #: V0003
      CAS号码 #： 923564-51-6纯度 ≥98%

      Description: Navitoclax (formerly ABT-263) is a novel, highly potent, orally bioavailable small-molecule inhibitor of the BCL (B-cell leukemia) protein family such as Bcl-xL, Bcl-2 and Bcl-w with Ki of ~ 0.5 nM, ~1 nM and ~1 nM in cell-free assays. It has potential anticancer activity and is currently undergoing Phase studies for the treatment of both solid and liquid tumors. ABT-263 mimicks the Bad-like BH3 and binds to Bcl-2 family proteins Bcl-2, Bcl-xl and Bcl-w which disrupts the interaction between Bcl-2/Bcl-xl /Bcl-w and pro-apoptotic proteins such as Bim(Bcl-2-interacting mediator of cell death), Bad (Bcl-2-associated death promoter) and Bak(BCL2-antagonist/killer 1), eventually it will trigger the caspases-initiated cell death pathway to induce apoptosis.

      References:  Cancer Res. 2008, 68(9), 3421-428.; Clin Cancer Res, 2008, 14(11), 3268-77.
      Customer Validation
      InvivoChem产品被CNS顶刊文章引用
      • Citation of InvivoChem Vorinostat/SAHA (V0255) by Nature 2021, 597(7874):119-125.
      • Citation of InvivoChem Larotrectinib (V2599) by Cell 2020, 183(5):1202-1218.e25
      • Citation of InvivoChem Eprenetapopt (APR-246) by Science Adv 2022: 8, eabm9427.
      • Citation of InvivoChem 5-azacytidine (V0404) by Nature 2021, 597(7874):119-125.
      • Citation of InvivoChem Larotrectinib (V2599) by Cell 2020, doi: 10.1016/j.cell.2020.10.016.
      • Citation of InvivoChem Eprenetapopt (APR-246) by Science Adv 2022, doi: 10.1126/sciadv.abm9427.
      • Citation of InvivoChem Vorinostat/SAHA (V0255) by Nature 2021, DOI: 10.1038/s41586-021-03850-3.
      • Citation of InvivoChem Vitrakvi by Cell 2020, PMID: 33142117 PMCID: PMC8100789
      • Citation of InvivoChem Eprenetapopt (APR-246) by Science Adv 2022, PMID: 36103522.
      • Citation of InvivoChem 5-azacytidine (V0404) by Nature 2021, DOI: 10.1038/s41586-021-03850-3.
      • Citation of InvivoChem LOXO-101 by Cell 2020, PMID: 33142117 PMCID: PMC8100789
      • Citation of InvivoChem Eprenetapopt (APR-246) by Science Adv 2022, PMID: 36103522.
      • Citation of InvivoChem Vorinostat/SAHA (V0255) by Nature 2021, PMID: 34433969
      • Citation of InvivoChem ARRY-470 by Cell 2020, PMID: 33142117 PMCID: PMC8100789
      • Citation of InvivoChem Eprenetapopt (APR-246) by Science Adv 2022: 8, eabm9427.
      • Citation of InvivoChem 5-azacytidine (V0404) by Nature 2021, PMID: 34433969
      • Citation of InvivoChem BMH-21 (V1435) by Cell Stem Cell 2020, 26(6): 845-861.e12.
      • Citation of InvivoChem Eprenetapopt (APR-246) by Science Adv 2022: 8, eabm9427.
      • Citation of InvivoChem BMH-21 (V1435) by Cell Stem Cell 2020, 26(6): 845-861.e12.
      • Citation of InvivoChem BMS-582949 (V2668) by Cells 2020, 9(6):1472.
      • Citation of InvivoChem Resveratrol (V0430) by Arterioscler Thromb Vasc Biol 2020, 40(10):2408
      • Citation of InvivoChem LGK974 /WNT974 (V1353) by Cancer Cell 2021 Apr 12;39(4):529-547.e7.
      • Citation of InvivoChem V1386 Napabucasin (BBI-608) by J Exp Clin Cancer Res 2021 Oct 13;40(1):319.
      • Citation of InvivoChem S63845 (V2797) by Cell Death and Disease 2020, 11:316.
      • Citation of InvivoChem LGK974 /WNT974 (V1353) by Cancer Cell 2021 Apr 12;39(4):529-547.e7.
      • Citation of InvivoChem Apiin (V4467) by J Med Chem 2020, 63(15):8338-8358.
      • Citation of InvivoChem V0001 venetoclax by WO2021231323A1

      2023产品目录2023-2024产品目录

      2023产品目录

      2023产品目录产品使用说明书(通用型)

      顾客使用 InvivoChem产品发表科研文献
      • 产品理化性质和储存条件
      • 实验参考方法
      • 质控文件
      • 生物活性
      • 顾客评价
      Molecular Weight (MW)974.61
      FormulaC47H55ClF3N5O6S3
      CAS No.923564-51-6
      Storage-20℃ for 3 years in powder form
      -80℃ for 2 years in solvent
      Solubility (In vitro)DMSO: 100 mg/mL (102.6 mM)
      Water: <1 mg/mL (slightly soluble or insoluble)
      Ethanol: <1 mg/mL
      Solubility (In vivo)55% DMSO+Corn oil: 8mg/mL
      SynonymsNavitoclax; ABT 263; ABT-263; ABT263
      SMILES CodeO=C(NS(=O)(C1=CC=C(N[C@H](CCN2CCOCC2)CSC3=CC=CC=C3)C(S(=O)(C(F)(F)F)=O)=C1)=O)C4=CC=C(N5CCN(CC6=C(C7=CC=C(Cl)C=C7)CCC(C)(C)C6)CC5)C=C4
      • 摩尔计算器
      • 稀释计算器
      • The molarity calculator equation

        Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

        • Mass
        • Concentration
        • Volume
        • Molecular Weight *
        • =
        • ×
        • ×
      • The dilution calculator equation

        Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

        This equation is commonly abbreviated as: C1V1 = C2V2

        • Concentration (start)
        • ×
        • Volume (start)
        • =
        • Concentration (final)
        • ×
        • Volume (final)
        • ×
        • =
        • ×
        • C1
        •  
        • V1
        •  
        • C2
        •  
        • V2
      GeneralWhen ABT-263 is administered at 100 mg/kg/day in the H345 xenograft model, significant antitumor efficacy is observed with 80% TGI and 20% of treated tumors indicating at least a 50% reduction in tumor volume.
      Animal modelC.B -17 scid-bg or C.B -17 scid mice
      FormulationFormulated in 10% ethanol, 30% polyethylene glycol 400, and 60% Phosal 50 PG
      Dosages100 mg/kg/day
      AdministrationOral gavage
      ReferenceCancer Res. 2008, 68(9), 3421-428.; Clin Cancer Res, 2008, 14(11), 3268-77.

      These protocols are for reference only. InvivoChem does not independently validate these methods.

      ABT-263 (Navitoclax)

      ABT-737, or ABT-263 at the indicated doses for 24 hours. Survival data are shown for transitional B cells (n = 3 mice for each genotype) and are the results of 3 independent experiments, each performed in triplicate. Experiments depicted in panels C and D were performed concurrently. Values represent mean ± SEM.
      		 

      ABT-263 (Navitoclax)

      		 

      ABT-263 (Navitoclax)

      As an inhibitor of Bcl-2, ABT263 is effective to reduce cell viability in HG3-CLL cells. Incubating the cells with ABT263 in 96 well plates (3×104 cells per well) for 24h shows a dose-dependent inhibition of cell viability with EC50 value of 2μM.

      评论

        Home Prev Next Last page / pices

        发评论

        ×
        你的资料在我们这儿很安全* 必填项。
        InvivoChem的所有产品仅用于作科学研究，不面向患者销售
        联系我们
        联系我们
        电话：020-31522723
        QQ：463611831
        电子邮箱: sales@invivochem.net
        获得最新产品资讯、折扣和优惠
        • 姓名*
        • *
        • 邮箱*
        • *
        • 详细说明：
        • *
        Copyright 2020 InvivoChem LLC | All Rights Reserved
        粤ICP备20063088号
          网站地图